AI for Builders Depends on Institutional Knowledge
The initiative’s drafters — tax law professors at the University of California Berkeley, University of Missouri, and UC Davis — project it would raise approximately $100 billion for healthcare, food assistance, and public education. The most high-profile targets include Google co-founder Sergey Brin, whose net worth Forbes estimates at $270 billion, who reportedly purchased a…
News release Under plans in a consultation published today, funded reinsurance – which involves UK life insurers paying a large up-front premium to a reinsurer in return for future payments – would be treated more like other investments that UK life insurers hold, ending a regulatory inconsistency. As a result, UK life insurers using funded…
Foreclosure filings surged by more than 20% through the first half of 2026, with numbers reflecting a return to historical patterns rather than heightened risk, according to a new report from Attom. Processing Content Filings in the form of default notices, scheduled auctions or bank repossessions appeared on the records of 227,548 residential units between…
L&G Asset Management has made acquisitions in the United States before, but never developed its own ground-up project…until now. The United Kingdom-based company bought a site at 292 Baker Avenue in Concord, a suburb of Boston, the Boston Business Journal reported. It closed on the site last week for $4.75 million, according to property records….
JBG Smith has postponed the release of its second-quarter earnings after a D.C. court ordered the Bethesda-based REIT, among others, to pay approximately $356M in damages in a lawsuit over its luxury condo building in Woodley Park. Photo credit: Google Maps Wardman Tower in Woodley Park The company was scheduled to release its earnings after…
The FDA IND clearance supports the initiation of RiboX’s Phase 1 clinical trial evaluating targeted LNP-delivered circular RNA-based in vivo CAR-T therapy for autoimmune cytopenias. RXIM002 represents the world’s first circular RNA-based in vivo CAR-T therapy achieving FDA IND clearance. RiboX expands its clinical-stage pipeline through its proprietary targeted LNP delivery platform. SHANGHAI and CAMBRIDGE,…